OPTICATH CENTRAL VENOUS OXIMETRY PROBE WITH SEAL WITH HEPARIN— 510(k) K062999

Substantially Equivalent

Hospira, Inc.

FDA 510(k) clearance K062999 for OPTICATH CENTRAL VENOUS OXIMETRY PROBE WITH SEAL WITH HEPARIN, Substantially Equivalent on 2006-11-03. Applicant: Hospira, Inc.. Device class: 2.

Clearance details

Applicant
Hospira, Inc.
Product code
Code DQE
Device class
Class 2
Regulation
21 CFR 870.1230
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Lake Forest, IL, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code DQE

view all

More clearances from Hospira, Inc.

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.